Browse Category

NYSE:TMO News 26 December 2025 - 9 January 2026

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

New York, Jan 8, 2026, 19:50 EST — After-hours Thermo Fisher Scientific Inc (NYSE: TMO) shares barely budged in after-hours trading — the stretch after the 4 p.m. close — despite a 1.7% dip in Thursday’s regular session that ended at $606.50. During the day, shares swung between $604 and $623.20, with trading volume swelling past 3 million shares, nearly double the 50-day average. Just two days before, on Tuesday, the stock had hit a 52-week high of $628.08. MarketWatch The move matters now as Thermo Fisher stock nears a series of upcoming events following fresh highs, with trading volume
Thermo Fisher Scientific stock edges lower as TD Cowen lifts target and JPM conference nears

Thermo Fisher Scientific stock edges lower as TD Cowen lifts target and JPM conference nears

New York, January 8, 2026, 14:40 EST — Regular session Thermo Fisher Scientific Inc (TMO) shares slipped 0.25% to $615.61 on Thursday afternoon after touching $623.20 earlier in the session. About 1.5 million shares had changed hands. The pullback comes after a sprint that pushed the stock to a record close of $620.72 on Tuesday, when it notched a fresh 52-week high. Investors are now leaning into the next batch of signals, with little room for muddle. MarketWatch TD Cowen raised its price target on Thermo Fisher to $696 from $654 and kept a Buy rating, according to a note
Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

New York, Jan 7, 2026, 18:54 EST — After-hours Thermo Fisher Scientific shares slipped about 0.6% in after-hours trading on Wednesday to $617.15, after swinging between $611.93 and $626.40 during the session. The dip comes with the stock sitting near recent highs and the calendar tightening. Investors are staring at next week’s J.P. Morgan Healthcare Conference and Thermo Fisher’s quarterly results later this month, looking for a clean read on demand and the 2026 setup. On Tuesday, the company said it enrolled the first patient in a new PPD CorEvitas obesity registry, a prospective study meant to collect “real-world evidence”
Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings

Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings

New York, Jan 7, 2026, 14:12 EST — Regular session Thermo Fisher Scientific shares edged lower on Wednesday after TD Cowen raised its price target on the life-sciences tools maker, with investors taking stock after the stock’s sprint to a fresh 52-week high. Benzinga The pullback matters because Thermo Fisher is coming into a busy stretch of scheduled events. Chief Executive Marc Casper is due to present at the J.P. Morgan Healthcare Conference on Jan. 13, and quarterly results follow on Jan. 29 — two chances for management to frame demand from pharma and biotech customers after a strong start
Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus

Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus

New York, January 6, 2026, 19:58 (EST) — After-hours Thermo Fisher Scientific Inc (TMO) shares were little changed in after-hours trading on Tuesday, after the stock closed up 1.56% at $620.72 and logged a new 52-week high. The shares traded between $602.40 and $628.05 during the session as U.S. stocks climbed, while volume topped the 50-day average, MarketWatch data showed. MarketWatch The rally puts a spotlight on what management says next week at the JPMorgan Healthcare Conference, where CEO Marc Casper is scheduled to speak on Jan. 13 at 11:15 a.m. ET. Investors often use the conference for the first
Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO

Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO

New York, Jan 5, 2026, 21:32 EST — Market closed Thermo Fisher Scientific Inc shares rose 3.2% to close at $611.20 on Monday, after trading between $590 and $611.60 and hitting a fresh 52-week high. Evercore ISI lifted its price target — an analyst estimate for where a stock could trade — to $650 from $610 and kept an “Outperform” rating, meaning it expects the shares to beat the broader market. Marketscreener data showed a consensus “Buy” rating and an average target price of $641.57. marketwatch.com+2Moomoo+2 The rally comes as investors position ahead of late-January earnings and look for clarity
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

New York, Jan 5, 2026, 14:59 EST — Regular session Thermo Fisher Scientific Inc shares rose about 2.4% in afternoon trading on Monday after Evercore ISI raised its price target to $650 from $610 and kept an “outperform” rating, a call that signals expectations for the stock to beat the broader market. The stock was last up 2.4% at $606.63, after swinging between $590.00 and $608.29 on volume of about 1.6 million shares. MarketScreener The move puts Thermo Fisher back on screens ahead of its late-January results, when investors will look for fresh clues on drugmaker and laboratory spending that
Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings

Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings

NEW YORK, January 4, 2026, 19:53 ET — Market closed Thermo Fisher Scientific Inc shares closed Friday up about 2.3% at $592.51, beating the broader market’s modest advance in the first session of 2026. Reuters The move matters heading into Monday because investors are rotating from thin holiday trade into a January calendar packed with economic data and the start of earnings season. Thermo Fisher’s results later this month will be one of the first big readouts for life-science tools demand. Thermo Fisher Scientific Thermo Fisher is a bellwether for “life science tools” — lab instruments, consumables and services used
Thermo Fisher stock closes higher near 52-week high as January data, earnings loom

Thermo Fisher stock closes higher near 52-week high as January data, earnings loom

NEW YORK, January 4, 2026, 15:25 ET — Market closed Thermo Fisher Scientific Inc (NYSE:TMO) shares rose 2.25% to $592.51 on Friday, outpacing a modestly higher U.S. stock market and moving back toward the top of their 52-week range. MarketWatch That positioning matters going into a new week when investors will be testing whether early-2026 risk appetite holds and how much room the Federal Reserve has to cut rates. Life sciences tools makers like Thermo Fisher tend to trade on expectations for lab and drug-development spending, which can shift quickly when rates and growth expectations move. Traders will get fresh
Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom

New York, Jan 3, 2026, 14:41 ET — Market closed Thermo Fisher Scientific Inc (NYSE: TMO) shares rose 2.25% to $592.51 on Friday, outpacing a modest gain in the S&P 500. The life-sciences tools maker ended the session about 3% below its 52-week high, with trading volume above its 50-day average, according to MarketWatch data. MarketWatch The move matters because it keeps Thermo Fisher near record territory as investors start to position for late-January earnings. With the stock already priced at a premium to many healthcare names, the next set of guidance and order commentary is likely to drive the
Thermo Fisher stock jumps 2% to start 2026 as investors turn to Jan. 29 earnings

Thermo Fisher stock jumps 2% to start 2026 as investors turn to Jan. 29 earnings

NEW YORK, January 2, 2026, 20:02 ET — Market closed Thermo Fisher Scientific Inc (NYSE: TMO) shares rose 2.25% to $592.51 on Friday, outpacing the S&P 500’s 0.19% gain in the first session of 2026. The stock finished about 3% below its 52-week high of $610.97, and trading volume of roughly 2.1 million shares ran above its 50-day average of about 1.7 million. MarketWatch The outperformance came as Wall Street steadied after a late-December slide, with the Dow and S&P 500 ending higher and snapping a four-day losing streak, Reuters reported. “The market is seeing a ‘buy the dip, sell
Thermo Fisher Scientific (TMO) Stock: Key News, Analyst Forecasts, and Catalysts to Watch Before the Market Opens on Dec. 26, 2025

Thermo Fisher Scientific (TMO) Stock: Key News, Analyst Forecasts, and Catalysts to Watch Before the Market Opens on Dec. 26, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) heads into the Friday, Dec. 26, 2025 U.S. market open coming off a holiday-shortened stretch: U.S. exchanges were closed on Christmas Day (Dec. 25) and closed early on Christmas Eve (Dec. 24). TechStock² As of the most recent trading data available (the shortened Dec. 24 session), TMO last traded around $579, implying a market capitalization of roughly $221B. The stock’s 52‑week range sits near $507 to $611, putting shares within striking distance of their yearly high going into year-end trading. For investors and traders looking at Thermo Fisher stock before the opening bell on

Stock Market Today

Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop